A recent alert issued by the Directorate of Drugs Control, Punjab, highlights serious concerns about using intravenous (IV) ceftriaxone with calcium-containing products, such as Ringer Lactate. This alert is based on reports of adverse drug reactions and underscores the risk of IV admixture incompatibility. Healthcare professionals are advised to take immediate action to ensure patient safety. Details of the Alert Issued By: Punjab Pharmacovigilance Center Key Concern Using IV ceftriaxone and calcium-containing products together can cause severe, potentially fatal complications due to precipitation in the bloodstream. This issue is particularly critical in neonates but extends to older infants and adults under specific conditions. Pharmacovigilance Center Findings The Pharmacovigilance Center in Punjab has reported numerous adverse reactions related to the combined use of IV ceftriaxone and calcium-containing products. Investigations revealed: ...
By: Shabir Hussain Jhatial The Ministry of Health, in collaboration with UNICEF, WHO, Pakistan Paediatric Association, and MAP, has launched a 4-Day Emergency Obstetric & Neonatal Care (EmONC) Masters Training Workshop in Islamabad. This initiative aims to address Pakistan’s high maternal and neonatal mortality rates, which are among the highest globally. Background Statistics:- Maternal Mortality Rate: 186/100,000, Neonatal Mortality Rate: 42/1000, Stillbirth Rate: 30 per 1,000 live births Workshop Objectives: -Equip top leadership of gynecologists and midwives with necessary skills and knowledge to address -Improve healthcare services and reduce mortality rates -Integrate new Emergency Neonatal Care (ENCC) materials developed with Laerdal Global Health and the American Academy of Pediatrics while the critical training was facilitated two Midwives teachers from Norway Ms. Patricia Titulier and Ms. Julia both Midwife Instructors. Trainer Midwives & Trainees Besid...